EJ Ellis- Grosse

Evelyn Ellis-Grosse, PhD., currently serves as Chief Scientific Officer of Zavante and has worked in clinical research and therapeutic drug development for over 20 years spanning areas of phase 1-4 therapeutic development. Dr. Ellis-Grosse is formerly of Wyeth (Pfizer) where she held positions of increasing responsibilities including AVP and Director of the Global Division of Anti-infective Clinical Research and Development. In this capacity, she defined and implemented strategic goals and priorities for the Infectious Disease therapeutic franchise. She was responsible for scientific and operational planning, management and execution of multiple global drug development programs, including those for targeting MDR pathogens.

EJ Ellis- Grosse is the CSO at Zavante Therapeutics. With a background in Biotechnology, EJ Ellis- Grosse has a rich history of leadership and innovation.EJ Ellis- Grosse studied B.Sc Biology at Judson College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.